RedHill Biopharma (RDHL) Reports Q4 Operating Loss of $20.7M
Go back to RedHill Biopharma (RDHL) Reports Q4 Operating Loss of $20.7M| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.58 +0.03 (5.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.55 | 52 Week High | $16.54 | |||
| Open | $0.57 | 52 Week Low | $8.10 | |||
| Day High | $0.59 | P/E | N/A | |||
| Day Low | $0.57 | EPS | $0.00 | |||
| Volume | 177,771 | |||||

